Citation Impact
Citing Papers
Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus
2009 StandoutNobel
Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis
2010 Standout
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
2004 StandoutNobel
Synovial membrane expression of matrix metalloproteinases and tissue inhibitor 1 in juvenile idiopathic arthritides.
2002
The Croonian Lecture, 1993. The endothelium: maestro of the blood circulation
1994 Nobel
Criteria for rheumatic disease. different types and different functions
1994
Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix
2009
Heterozygous Mutations in TREX1 Cause Familial Chilblain Lupus and Dominant Aicardi-Goutières Syndrome
2007 StandoutNobel
Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis
2008
Haemoglobinopathies and the rheumatologist
2016
HLA and Autoimmunity in Scleroderma (Systemic Sclerosis)
1995
The relationship between social support and physiological processes: A review with emphasis on underlying mechanisms and implications for health.
1996 Standout
Small-Vessel Vasculitis
1997 Standout
Sjögren's syndrome
2005 Standout
Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006
2010
Rheumatoid arthritis
2016 Standout
The incidence of cancer associated with the treatmentof rheumatoid arthritis
1999
Renal vascular effects of the selective endothelin receptor antagonists in anaesthetized rats
1997 StandoutNobel
Accelerated Systemic Autoimmunity in the Absence of Somatic Hypermutation in 564Igi: A Mouse Model of Systemic Lupus with Knocked-In Heavy and Light Chain Genes
2017 StandoutNobel
Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis
2006
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
2007 StandoutNobel
Criterion-related validity of the Borg ratings of perceived exertion scale in healthy individuals: a meta-analysis
2002
Role of platelet-derived growth factors in physiology and medicine
2008 Standout
Cellular senescence in aging and age-related disease: from mechanisms to therapy
2015 Standout
Modified-release sildenafil reduces Raynaud's phenomenon attack frequency in limited cutaneous systemic sclerosis
2011
Whole-Genome Screening in Ankylosing Spondylitis: Evidence of Non-MHC Genetic-Susceptibility Loci
2001
Monocytes of Patients with Systemic Sclerosis (Scleroderma) Spontaneously Release In Vitro Increased Amounts of Superoxide Anion
1999
Juvenile idiopathic arthritis
2007 Standout
Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement
2005
Raynaud’s phenomenon: Epidemiology and risk factors
2002
Radiologic Investigation of Rheumatic Diseases
2007
Systemic sclerosis
2017 Standout
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Scleroderma
2009 Standout
Stimulatory Autoantibodies to the PDGF Receptor in Systemic Sclerosis
2006
Comparable heavy and light chain pairings in normal and systemic lupus erythematosus IgG+ B cells
2000 StandoutNobel
Cardiovascular death in rheumatoid arthritis: A population‐based study
2005
Cree encephalitis is allelic with Aicardi-Goutiéres syndrome: implications for the pathogenesis of disorders of interferon alpha metabolism
2003
Antithrombotic Therapy for VTE Disease
2012 Standout
Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group
2002 Standout
The mortality of rheumatoid arthritis
1994
Pharmacotherapy of Raynaudʼs Phenomenon
1996
Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges
2015
Matrix metalloproteinase inhibitors in rheumatic diseases
2001
Ankylosing spondylitis
2007 Standout
Protective and Damaging Effects of Stress Mediators
1998 Standout
Myocarditis
2011 Standout
Prevalence of Sjögren’s syndrome in a closed rural community
1997
Toll‐like receptor 9 signaling protects against murine lupus
2005
Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies
2002
Systemic sclerosis: a prototypic multisystem fibrotic disorder
2007 Standout
Sickle-cell disease
2010 Standout
A prospective study of protein excretion using short-interval timed urine collections in patients with lupus nephritis
2009
Aging and Hypothalamic-Pituitary-Adrenal Response to Challenge in Humans*
1994
Rheumatic diseases: the effects of inflammation on bone
2005
VH‐Gene Representation in Autoantibodies Reflects the Normal Human B‐Cell Repertoire
1992
Strength and vulnerability integration: A model of emotional well-being across adulthood.
2010 Standout
Primary systemic vasculitis
1997
Rheumatoid arthritis
2010 Standout
Rheumatoid arthritis
2001
Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus. Why some tests fail
1996
Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis
2002
The Proportion of Regulatory T Cells in Patients with Rheumatoid Arthritis: A Meta-Analysis
2016 StandoutNobel
Frequency of infection in patients with rheumatoid arthritis compared with controls: A population‐based study
2002
Anti–tumor necrosis factor α therapy and heart failure: What have we learned and where do we go from here?
2004
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
2013 Standout
Polymyositis and dermatomyositis
2003 Standout
Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies
2006 Standout
Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes
2002
Small RNAs are modified with N-glycans and displayed on the surface of living cells
2021 StandoutNobel
Cutting Edge: Ectopic Expression of CD40 Ligand on B Cells Induces Lupus-Like Autoimmune Disease
2002 StandoutNobel
Chronic Kidney Disease Diagnosis and Management
2019 Standout
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Quantity and Quality of Exercise for Developing and Maintaining Cardiorespiratory, Musculoskeletal, and Neuromotor Fitness in Apparently Healthy Adults
2011 Standout
Adipose Tissue, Inflammation, and Cardiovascular Disease
2005 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Review of teriflunomide and its potential in the treatment of multiple sclerosis
2009
ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
1996 Standout
Global Disparities of Hypertension Prevalence and Control
2016 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
2019 Standout
Histone H3 lysine 9 di-methylation as an epigenetic signature of the interferon response
2012 StandoutNobel
Analysis of antibodies to RNA in patients with systemic lupus erythematosus and other autoimmune rheumatic diseases
1991
Risky families: Family social environments and the mental and physical health of offspring.
2002 Standout
Systemic lupus erythematosus
2010
DRUG-INDUCED LUPUS
1994
Clinical Aspects of Calcium Pyrophosphate Dihydrate Crystal Deposition
1988
Mortality in rheumatoid arthritis
1995
Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis
2016 Standout
Mortality in rheumatoid arthritis: 2008 update.
2009
Osteoarthritis: New Insights. Part 1: The Disease and Its Risk Factors
2000 Standout
Osteoarthritis: an update with relevance for clinical practice
2011 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Integrating mechanisms of pulmonary fibrosis
2011 Standout
C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged Men
1999 Standout
Works of P Maddison being referenced
Oxford Textbook of Rheumatology
1993
Hydralazine induced lupus syndrome with eye disease.
1985
Cardiorespiratory responses to underwater treadmill walking in healthy females
1998
Leflunomide in rheumatoid arthritis: recommendations through a process of consensus
2005
VALIDITY AND RELIABILITY OF THREE METHODS USED IN THE DIAGNOSIS OF RAYNAUD'S PHENOMENON
1993
A double blind, randomised, multicentre comparison of two doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective tissue diseases.
1991
Arthropathy of hands and feet in systemic lupus erythematosus.
1990
Rheumatoid arthritis associated with myositis and anti-Jo-1 antibody.
1993
Osteoarthritis and articular chondrocalcinosis in the elderly.
1983
Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation.
1994
Independent analysis of the 16/6 idiotype lupus model. A role for an environmental factor?
1991
Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients.
1990
Criteria for assessing disease activity in systemic lupus erythematosus.
1989
Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus. Members of the British Isles Lupus Assessment Group (BILAG).
1988
Autoantibodies and immunogenetics in 30 patients with systemic sclerosis and their families.
1987
D-penicillamine withdrawal in rheumatoid arthritis.
1984